Centro en Red de Medicina Regenerativa de Castilla y Leon Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01183728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Centro en Red de Medicina Regenerativa de Castilla y Leon

Active Ingredients

Drugs in Phase 2 Trials (2)

autologous mesenchymal stem cells (1 trial)

bone autograft (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Cysts (Phase 2)

Cysts (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2